14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for PhaseBio Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for PhaseBio Pharmaceuticals Inc. is PHAS and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell PhaseBio Pharmaceuticals Inc. Stock?
PhaseBio Pharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy PhaseBio Pharmaceuticals Inc. Stock?
PhaseBio Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy PhaseBio Pharmaceuticals Inc. Stock.

What's the current price of PhaseBio Pharmaceuticals Inc. Stock?
As of the end of day on the Apr 03, 2023, the price of an PhaseBio Pharmaceuticals Inc. (PHAS) share was $0.0701.

What is the 52-week high and low for PhaseBio Pharmaceuticals Inc. Stock?
The 52-week high for PhaseBio Pharmaceuticals Inc. Stock is $1.69 and the 52-week low is $0.0100.
Click to get the best stock tips daily for free!

About PhaseBio Pharmaceuticals Inc.

PhaseBio Pharmaceuticals. PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel for cardiovascular diseases. Its lead product candidate is bentracimab (PB2452), a reversal agent for the antiplatelet drug ticagrelor that is in Phase III clinical trial for patients with uncontrolled major or life-threatening bleeding events or in patients requiring urgent or an invasive procedure. The company is... PHAS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT